buspirone orion 10 mg
orion corporation - espoo - buspironhydroklorid - tablett - 10 mg
buspirone orion 5 mg
orion corporation - espoo - buspironhydroklorid - tablett - 5 mg
basiron ac 5 %
galderma nordic ab - benzoylperoksid, vandig - gel - 5 %
basiron ac 10 %
galderma nordic ab - benzoylperoksid, vandig - gel - 10 %
basiron ac wash 5 %
galderma nordic ab - benzoylperoksid, vandig - gel - 5 %
rimstar
sandoz - københavn - rifampicin / isoniazid / pyrazinamid / etambutolhydroklorid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg / 275 mg
rimstar
2care4 aps - rifampicin / isoniazid / pyrazinamid / etambutolhydroklorid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg / 275 mg
methylthioninium chloride proveblue
provepharm sas - metyltioniniumklorid - methemoglobinemi - alle andre terapeutiske produkter - akutt symptomatisk behandling av medisinske og kjemiske produkter-induserte metaemoglobinemi. methylthioninium klorid proveblue er indisert hos voksne, barn og ungdom (i alderen 0 til 17 år gamle).
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
citalopram orion 40 mg
orion corporation orion pharma - citalopramhydrobromid - tablett, filmdrasjert - 40 mg